NCT00343148View on ClinicalTrials.gov

Pharmacokinetic Study of a Single Dose of AVI-4126 (RESTEN-NG®) in Cerebral Spinal Fluid

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

June 30, 2006

Study Completion Date

June 30, 2009

Conditions
Neoplasms
Interventions
DRUG

AVI-4126 Injection (RESTEN-NG®)

Trial Locations (1)

98418

NW Kinetics, Tacoma

All Listed Sponsors
lead

Sarepta Therapeutics, Inc.

INDUSTRY

NCT00343148 - Pharmacokinetic Study of a Single Dose of AVI-4126 (RESTEN-NG®) in Cerebral Spinal Fluid | Biotech Hunter | Biotech Hunter